GENORAY CO., LTD.

Financials Genoray Co., Ltd.

Equities

A122310

KR7122310006

Advanced Medical Equipment & Technology

End-of-day quote Korea S.E. Other stock markets 03:30:00 14/05/2024 am IST			5-day change	1st Jan Change
6,500 ^KRW	-0.31%		+0.78%	-7.14%

19/04	Genoray Co., Ltd. announces an Equity Buyback for KRW 4,000 million worth of its shares.	CI
19/04	Genoray Co., Ltd. authorizes a Buyback Plan.	CI

Valuation

Fiscal Period: December	2018	2019	2020	2021	2022	2023
Capitalization ¹	81,039	1,01,386	1,39,365	1,41,509	1,08,181	95,597
Enterprise Value (EV) ¹	70,022	86,228	1,24,018	1,22,360	93,600	1,00,542
P/E ratio	9.22 x	8.04 x	13.8 x	9.88 x	7.83 x	7.68 x
Yield	1.55%	1.8%	1.23%	1.72%	2.07%	2.29%
Capitalization / Revenue	1.44 x	1.56 x	2.26 x	1.9 x	1.31 x	0.98 x
EV / Revenue	1.24 x	1.32 x	2.01 x	1.65 x	1.13 x	1.03 x
EV / EBITDA	5.37 x	4.84 x	8.62 x	6.6 x	5.05 x	5.9 x
EV / FCF	467 x	45.6 x	82.5 x	127 x	-20.9 x	-15.7 x
FCF Yield	0.21%	2.19%	1.21%	0.79%	-4.78%	-6.38%
Price to Book	1.8 x	1.79 x	2.09 x	1.79 x	1.23 x	1 x
Nbr of stocks (in thousands)	12,532	13,732	14,294	14,294	13,977	13,657
Reference price ²	6,467	7,383	9,750	9,900	7,740	7,000
Announcement Date	28/02/19	28/02/20	26/02/21	25/02/22	28/02/23	21/03/24

¹KRW in Million²KRW

Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December	2018	2019	2020	2021	2022	2023
Net sales ¹	56,289	65,106	61,688	74,290	82,604	97,897
EBITDA ¹	13,051	17,821	14,384	18,529	18,551	17,035
EBIT ¹	10,958	14,668	11,119	14,968	14,918	12,757
Operating Margin	19.47%	22.53%	18.03%	20.15%	18.06%	13.03%
Earnings before Tax (EBT) ¹	11,046	14,982	10,700	15,787	15,704	12,961
Net income ¹	9,472	13,240	10,172	14,323	13,900	12,486
Net margin	16.83%	20.34%	16.49%	19.28%	16.83%	12.75%
EPS ²	701.0	917.8	709.0	1,002	988.0	911.5
Free Cash Flow ¹	149.9	1,890	1,503	962.4	-4,470	-6,413
FCF margin	0.27%	2.9%	2.44%	1.3%	-5.41%	-6.55%
FCF Conversion (EBITDA)	1.15%	10.6%	10.45%	5.19%	-	-
FCF Conversion (Net income)	1.58%	14.27%	14.77%	6.72%	-	-
Dividend per Share ²	100.0	133.0	120.0	170.0	160.0	160.0
Announcement Date	28/02/19	28/02/20	26/02/21	25/02/22	28/02/23	21/03/24

¹KRW in Million²KRW

Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December	2023 Q3
Net sales	-
EBITDA	-
EBIT	-
Operating Margin	-
Earnings before Tax (EBT)	-
Net income ¹	3.041
Net margin	-
EPS ²	223.0
Dividend per Share	-
Announcement Date	14/11/23

¹KRW in Billions²KRW

Estimates

Balance Sheet Analysis

Fiscal Period: December	2018	2019	2020	2021	2022	2023
Net Debt ¹	-	-	-	-	-	4,945
Net Cash position ¹	11,016	15,158	15,347	19,149	14,581	-
Leverage (Debt/EBITDA)	-	-	-	-	-	0.2903 x
Free Cash Flow ¹	150	1,890	1,503	962	-4,470	-6,413
ROE (net income / shareholders' equity)	27.3%	25.3%	16.1%	19.7%	16.7%	13.5%
ROA (Net income/ Total Assets)	14.2%	13.4%	8.46%	10.1%	9.07%	6.92%
Assets ¹	66,506	98,900	1,20,219	1,41,714	1,53,239	1,80,463
Book Value Per Share ²	3,589	4,124	4,654	5,522	6,294	6,982
Cash Flow per Share ²	815.0	1,005	1,292	1,403	362.0	379.0
Capex ¹	1,382	1,001	566	5,335	9,248	2,888
Capex / Sales	2.46%	1.54%	0.92%	7.18%	11.2%	2.95%
Announcement Date	28/02/19	28/02/20	26/02/21	25/02/22	28/02/23	21/03/24

¹KRW in Million²KRW

Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Medical Imaging Systems

	1st Jan change	Capi.
GENORAY CO., LTD.	-7.14%	65.05M
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.	-2.78%	15.37B
IRAY TECHNOLOGY COMPANY LIMITED	-37.28%	2.92B
SONOSCAPE MEDICAL CORP.	-12.11%	2.48B
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD.	-14.23%	1.45B
CORETAG, INC.	-.--%	1.12B
NANO-X IMAGING LTD.	+66.72%	609M
GUERBET	+90.77%	499M
DETECTION TECHNOLOGY OYJ	+18.98%	249M
DRTECH CORPORATION	-2.35%	225M

Medical Imaging Systems

Stock Market
Equities
A122310 Stock
Financials Genoray Co., Ltd.

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW